PANORAMIC recruitment analysis
, T., Apr 2022
Analysis of the PANORAMIC trial recuitment suggesting that if the trial shows efficacy, the NNT will be >200.
Currently there are 51 molnupiravir studies and meta analysis shows:
| Outcome | Improvement |
|---|---|
| Mortality | 13% lower [4‑22%] |
| Ventilation | 20% lower [-19‑46%] |
| ICU admission | 6% lower [-15‑23%] |
| Hospitalization | 0% lower [-7‑7%] |
| Cases | 24% fewer [-1‑43%] |
Lee et al., 8 Apr 2022, preprint, 1 author.